236 related articles for article (PubMed ID: 34823889)
1. Scoring system evaluation for orbital exenteration in patients with rhino-orbito-cerebral mucormycosis.
Ulas B; Kursun E; Turunc T; Demıroglu YZ; Pelıt A
J Fr Ophtalmol; 2022 Jan; 45(1):47-52. PubMed ID: 34823889
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
[TBL] [Abstract][Full Text] [Related]
3. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.
Songu M; Unlu HH; Gunhan K; Ilker SS; Nese N
Am J Rhinol; 2008; 22(1):98-103. PubMed ID: 18284868
[TBL] [Abstract][Full Text] [Related]
4. Local Infiltration Anesthesia for Orbital Exenteration in Patients With Rhino-Orbital Cerebral Mucormycosis: A Case Series.
Veerabathula P; Singh S; Koshy PG; Dave TV; Rao RN; Naik MN
A A Pract; 2022 Apr; 16(4):e01581. PubMed ID: 35421003
[TBL] [Abstract][Full Text] [Related]
5. Orbital exenteration: The 10-year Massachusetts Eye and Ear Infirmary experience.
Nagendran ST; Lee NG; Fay A; Lefebvre DR; Sutula FC; Freitag SK
Orbit; 2016 Aug; 35(4):199-206. PubMed ID: 27322708
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis.
Kashkouli MB; Abdolalizadeh P; Oghazian M; Hadi Y; Karimi N; Ghazizadeh M
Br J Ophthalmol; 2019 Oct; 103(10):1460-1465. PubMed ID: 30514712
[TBL] [Abstract][Full Text] [Related]
7. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit of exenteration in COVID-19-associated rhino-orbital mucormycosis.
Raj A; Singh P; Sadhukhan K; Chandra B; Kranti B; Kumar S; Sinha U; Kokkayil P; Bhadani PP; Sinha P; Sanepalli S; Tiwari P; Nanda J
Indian J Ophthalmol; 2024 Feb; 72(2):190-194. PubMed ID: 38099361
[TBL] [Abstract][Full Text] [Related]
9. Non-Exenteration Management of Sino-Orbital Fungal Disease.
Athavale DD; Jones R; O'Donnell BA; Forer M; Biggs N
Ophthalmic Plast Reconstr Surg; 2017; 33(6):426-429. PubMed ID: 27768645
[TBL] [Abstract][Full Text] [Related]
10. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient.
Fairley C; Sullivan TJ; Bartley P; Allworth T; Lewandowski R
Ophthalmology; 2000 Mar; 107(3):555-8. PubMed ID: 10711895
[TBL] [Abstract][Full Text] [Related]
11. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
[TBL] [Abstract][Full Text] [Related]
12. Orbital Exenteration in Rhino-Orbito-Cerebral Mucormycosis: A Prospective Analytical Study with Scoring System.
Shah K; Dave V; Bradoo R; Shinde C; Prathibha M
Indian J Otolaryngol Head Neck Surg; 2019 Jun; 71(2):259-265. PubMed ID: 31275841
[TBL] [Abstract][Full Text] [Related]
13. Rhino-orbito-cerebral mucormycosis: a treatment dilemma.
Jeevanan J; Gendeh BS; Faridah HA; Vikneswaran T
Med J Malaysia; 2006 Mar; 61(1):106-8. PubMed ID: 16708746
[TBL] [Abstract][Full Text] [Related]
14. Localized surgical debridement for the management of orbital mucormycosis.
Murthy R; Gote YS; Bagchi A
Indian J Ophthalmol; 2022 Feb; 70(2):649-652. PubMed ID: 35086255
[TBL] [Abstract][Full Text] [Related]
15. Indications for orbital exenteration in mucormycosis.
Hargrove RN; Wesley RE; Klippenstein KA; Fleming JC; Haik BG
Ophthalmic Plast Reconstr Surg; 2006; 22(4):286-91. PubMed ID: 16855502
[TBL] [Abstract][Full Text] [Related]
16. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.
Veisi A; Bagheri A; Eshaghi M; Rikhtehgar MH; Rezaei Kanavi M; Farjad R
Eur J Ophthalmol; 2022 Jul; 32(4):NP11-NP16. PubMed ID: 33843287
[TBL] [Abstract][Full Text] [Related]
17. Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience.
Ramamurthy LB; Bhandari R; Kanakpur S; Thejaswini P
Indian J Ophthalmol; 2022 Mar; 70(3):1019-1024. PubMed ID: 35225564
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities.
Pelton RW; Peterson EA; Patel BC; Davis K
Ophthalmic Plast Reconstr Surg; 2001 Jan; 17(1):62-6. PubMed ID: 11206749
[TBL] [Abstract][Full Text] [Related]
19. Rhino-orbital mucormycosis in a patient with acquired immunodeficiency syndrome (AIDS) and neutropenia.
Hejny C; Kerrison JB; Newman NJ; Stone CM
Am J Ophthalmol; 2001 Jul; 132(1):111-2. PubMed ID: 11438066
[TBL] [Abstract][Full Text] [Related]
20. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
